Avon Organics receives USFDA approval for Biotech facility at Solapur

Avon Organics Ltd has announced that the Company has received USFDA approval for its facilities at Biotech Division, situated at Solapur, Maharashtra, for manufacture of Psuedoephedrine. This will enable the Company to enter into regulated markets in US.

The stock was trading at Rs.18, up by Rs.1.70 or 10.43%. The stock hit an intraday high of Rs.18.55 and low of Rs.16.60. The total traded quantity was 230940 compared to 2 week average of 29973.

Source : Equity Bulls

Keywords